Ear­ly can­cer vac­cine da­ta breathe new life in­to the field, but many ques­tions re­main: #AACR24

SAN DIEGO — Sci­en­tists have long dreamed of cre­at­ing vac­cine-like treat­ments that could teach the im­mune sys­tem to tar­get tu­mors. Af­ter decades of false starts, that idea is fi­nal­ly get­ting clos­er to re­al­i­ty.

A new gen­er­a­tion of ex­per­i­men­tal can­cer vac­cines was on cen­ter stage at the Amer­i­can As­so­ci­a­tion for Can­cer Re­search con­fer­ence this week in San Diego, rang­ing from “off-the-shelf” shots to high­ly cus­tomized in­jec­tions match­ing the unique ge­net­ic make­up of a pa­tient’s tu­mor.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER